Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Winter-onset alopecia areata patients are more likely to regrow hair within a year compared to spring-onset patients.

Erdr1 could be a new marker for diagnosing hair loss.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

New treatments for severe alopecia areata show promise but lack standard approval.

Microneedling can effectively promote hair regrowth in alopecia areata.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Oral alitretinoin can quickly regrow hair in alopecia universalis.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.